Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation

Mycoses

Volumn 56, Issue 3, 2013, Pages 350-357

  Lichtenstern, Christoph ^a,b   Hochreiter, Marcel ^b   Zehnter, Verena D ^b   Brenner, Thorsten ^b   Hofer, Stefan ^b   Mieth, Markus ^b   Büchler, Markus W ^b   Martin, Eike ^b   Weigand, Markus A ^a,b   Schemmer, Peter ^b   Busch, Cornelius J ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Aspergillus; Candida; Colonisation; Fungal infections; Liver transplantation; Model for end stage liver disease

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; BLOOD TRANSFUSION; CANDIDIASIS; CHILD TURCOTTE PUGH SCORE; END STAGE LIVER DISEASE; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OPERATION DURATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTIFUNGAL AGENTS; APACHE; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS, INVASIVE; END STAGE LIVER DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OPERATIVE TIME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

ASPERGILLUS; CANDIDA; FUNGI;

EID: 84876328321     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12041     Document Type: Article

References (44)

1. Hagerty JA, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect (Larchmt) 2003; 4: 263-71. Epub 2003/11/01.
2. Pappas PG, Alexander BD, Andes DR et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101-11. Epub 2010/03/12.
3. Singh N. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design. Clin Infect Dis 2004; 39(Suppl. 4): S200-6.
4. Singh N, Avery RK, Munoz P et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46-52.
5. Salavert M. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?Int J Antimicrob Agents 2008; 32(Suppl. 2): S149-53. Epub 2008/12/17.
6. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007; 45: 305-20. Epub 2007/05/19.
7. Patel R, Portela D, Badley AD et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 1996; 62: 926-34. Epub 1996/10/15.
8. Singh N, Wagener MM, Marino IR, Gayowski T. Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation 2002; 73: 63-7. Epub 2002/01/17.
9. Husain S, Tollemar J, Dominguez EA et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023-9. Epub 2003/06/28.
10. Fortun J, Martin-Davila P, Moreno S et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8: 1065-70.
11. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70. Epub 2001/02/15.
12. Freeman RB, Harper A, Edwards EB. Excellent liver transplant survival rates under the MELD/PELD system. Transpl Proc 2005; 37: 585-8. Epub 2005/04/26.
13. Freeman RB Jr, Wiesner RH, Harper A et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-8. Epub 2002/08/30.
14. Saab S, Wang V, Ibrahim AB et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473-6. Epub 2003/05/13.
15. Earl TM, Cooil B, Rubin JE, Chari RS. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics. Transplantation 2008; 86: 238-44. Epub 2008/07/23.
16. Weismuller TJ, Negm A, Becker T et al. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transpl Int 2009; 22: 970-8. Epub 2009/07/22.
17. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21. Epub 2008/05/09.
18. Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000; 31: 545-53.
19. Cruciani M, Mengoli C, Malena M, Bosco O, Serpelloni G, Grossi P. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl 2006; 12: 850-8. Epub 2006/04/22.
20. Neofytos D, Fishman JA, Horn D et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12: 220-9. Epub 2010/02/02.
21. Dutkowski P, Oberkofler CE, Bechir M et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl 2011; 17: 674-84. Epub 2011/05/28.
22. Oberkofler CE, Stocker R, Raptis DA et al. Same quality - higher price? The paradox of allocation: the first national single center analysis after the implementation of the new Swiss transplantation law: the ICU view. Clin Transplant 2011; 25: 921-8. Epub 2010/11/27.
23. Machicao VI, Srinivas TR, Hemming AW et al. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006; 12: 754-61. Epub 2006/03/11.
24. Benckert C, Quante M, Thelen A et al. Impact of the MELD allocation after its implementation in liver transplantation. Scand J Gastroenterol 2011; 8: 941-8. Epub 2011/03/30.
25. Ferraz-Neto BH, Zurstrassen MP, Hidalgo R et al. Analysis of liver transplantation outcome in patients with MELD Score > or = 30. Transpl Proc 2008; 40: 797-9. Epub 2008/05/06.
26. Xia VW, Du B, Braunfeld M et al. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl 2006; 12: 614-20. Epub 2006/03/24.
27. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?Am J Transpl 2006; 6: 2651-9. Epub 2006/08/31.
28. Weismuller TJ, Fikatas P, Schmidt J et al. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - limitations of the 'sickest first'-concept. Transpl Int 2011; 24: 91-9. Epub 2010/09/08.
29. Marik PE. Fungal infections in solid organ transplantation. Expert Opin Pharmacother 2006; 7: 297-305.
30. Pappas PG, Andes D, Schuster M et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant 2006; 6: 386-91. Epub 2006/01/24.
31. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35. Epub 2009/02/05.
32. Onaca N, Levy MF, Ueno T et al. An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int 2006; 19: 282-7. Epub 2006/04/01.
33. Washburn WK, Pollock BH, Nichols L, Speeg KV, Halff G. Impact of recipient MELD score on resource utilization. Am J Transpl 2006; 6: 2449-54. Epub 2006/08/08.
34. Bruns H, Hillebrand N, Schneider T et al. LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Clin Transplant 2011; 25: E558-65. Epub 2011/05/19.
35. Foxton MR, Al-Freah MA, Portal AJ et al. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl 2010; 16: 668-77. Epub 2010/05/05.
36. Yoo HY, Thuluvath PJ. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int 2005; 25: 536-41. Epub 2005/05/25.
37. Habib S, Berk B, Chang CC et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006; 12: 440-7. Epub 2006/02/25.
38. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther 2005; 21: 169-77. Epub 2005/02/01.
39. Rana A, Hardy MA, Halazun KJ et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transpl 2008; 8: 2537-46. Epub 2008/10/24.
40. Ravaioli M, Grazi GL, Ballardini G et al. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transpl 2006; 6: 1572-7. Epub 2006/07/11.
41. Onaca NN, Levy MF, Sanchez EQ et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117-23. Epub 2003/01/28.
42. Jacob M, Copley LP, Lewsey JD et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903-7. Epub 2004/07/09.
43. Nagler E, Van Vlierberghe H, Colle I, Troisi R, de Hemptinne B. Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective. Eur J Gastroenterol Hepatol 2005; 17: 849-56. Epub 2005/07/09.
44. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805. Epub 2007/02/28.